Health Care

Nektar Therapeutics (NASDAQ:NKTR) Takes Off in Trading Today - Up by 18.83%

Mizuho Securities analyst Difei Yang assigned a Buy rating to Nektar Therapeutics (NASDAQ: NKTR) today. American International Group Inc. now owns 118,366 shares of the biopharmaceutical company's stock valued at $2,841,000 after purchasing an additional 6,476 shares during the last quarter. This represents an increase of Infinity compared to the average daily volume of 0 call options.

In other news, CAO Jillian B. Thomsen sold 2,648 shares of the company's stock in a transaction dated Wednesday, August 16th. Ashmore Group Plc sold 21,355 shares as the company's stock rose 11.75% with the market. Following the sale, the chief executive officer now owns 122,908 shares in the company, valued at $1,705,963.04. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. $33,255 worth of stock was sold by Doberstein Stephen K on Tuesday, May 16. The stock was sold at an average price of $13.88, for a total transaction of $1,297,197.04. The company realized a fall in short interest of -1.29% between September 29, 2017 and October 13, 2017.

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Bank of New York Mellon Corp boosted its position in shares of Nektar Therapeutics by 0.6% during the second quarter.

Nektar Therapeutics has gapped open sharply higher Monday morning and is now up 8.38 at $40.88 on above average volume. Arizona State Retirement System now owns 80,945 shares of the biopharmaceutical company's stock valued at $1,582,000 after acquiring an additional 800 shares during the last quarter.

Vanguard Gp holds 0.01% in Nektar Therapeutics (NASDAQ:NKTR) or 14.01 million shares. LS Investment Advisors LLC now owns 6,594 shares of the biopharmaceutical company's stock worth $129,000 after purchasing an additional 535 shares during the period. It also increased its holding in Gran Tierra Energy Inc (NYSEMKT:GTE) by 345,800 shares in the quarter, for a total of 2.50M shares, and has risen its stake in Banco Macro Sa (NYSE:BMA). Institutional investors own 95.11% of the company's stock.

Equity Research firms now have a positive stance on shares of Nektar Therapeutics (NASDAQ:NKTR). Nektar Therapeutics has a 52 week low of $11.41 and a 52 week high of $33.67. For the past month, Nektar Therapeutics's stock has been 41.18%, 68.57% for the last quarter, 64.06% for the past six months and 137.57% for the past 52 weeks. The biopharmaceutical company reported ($0.32) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.36) by $0.04. The business had revenue of $36.30 million for the quarter, compared to analysts' expectations of $32.42 million.

"In the dose-escalation stage of the PIVOT trial, we've observed important response rates across all three tumor types - melanoma, renal cell carcinoma and non-small lung cancer - in both PD-L1 positive and PD-L1 negative patients", said Mary Tagliaferri, M.D., Senior Vice President of Clinical Development at Nektar Therapeutics. The firm's revenue for the quarter was up 321.2% on a year-over-year basis. During the same period last year, the firm earned ($0.32) earnings per share. sell-side analysts predict that Nektar Therapeutics will post -0.83 earnings per share for the current year. Finally, Brean Capital reissued a "buy" rating and set a $23.00 price objective on shares of Nektar Therapeutics in a research note on Friday, September 30th. World Asset Management Inc boosted its stake in Nektar Therapeutics by 5.6% in the 2nd quarter. Finally, Canaccord Genuity assumed coverage on shares of Nektar Therapeutics in a report on Thursday. Following the acquisition, the director now directly owns 121,333 shares of the company's stock, valued at $1,637,995.50. Aegis Capital initiated Nektar Therapeutics (NASDAQ:NKTR) on Tuesday, November 8 with "Buy" rating. Nektar Therapeutics has a consensus rating of "Buy" and an average target price of $28.64. Analysts' mean recommendation for the stock is 1.60 (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range).

Among 2 analysts covering IRSA Inversiones (NYSE:IRS), 1 have Buy rating, 0 Sell and 1 Hold. The stock's price is 39.99 and their relative strength index (RSI) stands at 90.97.

WARNING: This story was first posted by Week Herald and is the sole property of of Week Herald. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of United States & worldwide copyright legislation.



Like this

Latest


13 November 2017
Report Says Illinois Is Losing Well-Paid, Blue-Collar Jobs
Highly desirable skilled-industry positions are increasingly being given to workers with associate's degrees. In California, 47 percent of the good-paying jobs for workers without a bachelor's are in blue-collar work.

13 November 2017
Costco Wholesale Corporation (COST) Shares Sold by Comgest Global Investors SAS
Following the transaction, the director now directly owns 4,109 shares of the company's stock, valued at approximately $665,658. Costco Wholesale Corporation (NASDAQ:COST) closed up +2.25 points or 1.33% at $171.36 with 2.67 mln shares exchanging hands.

13 November 2017
Amitabh Bachchan: Marriages are wonderful
The Bachchans attended a family wedding recently, which means plenty of selfies and frame-worthy moments for the family album. Bachchan senior and Bachchan junior also opted for traditional sherwanis from the studios of their favourite designer duo.

13 November 2017
Sasnovich beats Stephens to take Fed Cup to deciding doubles
Open champion Sloane Stephens 4-6, 6-1, 8-6 to leave the final level at 2-2 on the indoor hard-court Chizhovka Arena. Vandeweghe then jumped out to a 5-0 lead before Sabalenka won her only game of the second set.

13 November 2017
House 'Committed' to Retaining Some State and Local Tax Deductions, Chairman Says
Eliminating some deductions hurts, for example, teachers who spend about $500 a year from their pockets to buy school supplies. Senate Republican leaders have said they want to hold a full Senate vote before Thanksgiving, which falls on November 23.

13 November 2017
Allegis Investment Advisors LLC Raises Stake in Wells Fargo & Company
Piper Jaffray Companies reiterated a "hold" rating on shares of Wells Fargo & in a research report on Sunday, July 30th. The Firm operates through four divisions: Agricultural Products, Pressurized Vessels, Modular Buildings and Tools.

13 November 2017
Three killed in crash involving deer in SE Kansas
One auto was heading north as a van driven by Sherry Bingham was heading south. According to the Kansas Highway Patrol, the crash happened around 1 a.m.

13 November 2017
RPS Group plc (RPS) PT Raised to GBX 330 at Liberum Capital
In other news, insider Brian Gilvary purchased 70 shares of the business's stock in a transaction dated Monday, September 11th. The shares were acquired at an average price of GBX 446 ($5.87) per share, with a total value of £312.20 ($410.63).

13 November 2017
Investors Spotlight: AK Steel Holding Corporation (AKS), Whiting Petroleum Corp. (WLL)
The analysts estimated mean EPS at 0.12 while the high and low EPS estimate stand at 0.2 and 0.03 respectively. A number of hedge funds and other institutional investors have recently modified their holdings of AKS.

13 November 2017
JP Morgan May Have Just Lost Faith in United Continental (NYSE:UAL)
Pacad Investment Ltd. purchased a new stake in shares of United Continental Holdings in the 2nd quarter worth about $3,306,000. The stock of United Continental Holdings Inc (NYSE:UAL) earned "In-Line" rating by Imperial Capital on Tuesday, November 22.



Recommended